GenSight Biologics Announces Publication of Results from LUMEVOQ® RESCUE Pivotal Phase III Trial in AAO journal Ophthalmology®

47th NANOS Annual Meeting – Virtual Meeting

GenSight Biologics Announces Publication of Results from LUMEVOQ® REVERSE Pivotal Phase III Trial and Non-Human Primate Study in Science Translational Medicine

American Academy of Ophthalmology 2020 – Virtual

GenSight Biologics reports validation of LUMEVOQ® Marketing Authorisation Application (MAA) by European Medicines Agency

Eyecelerator 2020 – Virtual Conference

World Orphan Drug Congress Europe 2020 – Live Digital

4th Annual Gene Therapy for Rare Disorders Europe – Virtual

Cell & Gene Meeting on the Mesa – Virtual

Ophthalmology Futures Retina – Virtual Forum